Cargando…
A draft conceptual model of SLC6A1 neurodevelopmental disorder
INTRODUCTION: SLC6A1 Neurodevelopmental Disorder (SLC6A1-NDD), first described in 2015, is a rare syndrome caused by a mutation in the SLC6A1 gene which encodes for the GABA Transporter 1 (GAT-1) protein. Epilepsy is one of the most common symptoms in patients and is often the primary treatment targ...
Autores principales: | Goodspeed, Kimberly, Mosca, Lindsay R., Weitzel, Nicole C., Horning, Kyle, Simon, Elijah W., Pfalzer, Anna C., Xia, Maya, Langer, Katherine, Freed, Amber, Bone, Megan, Picone, Maria, Bichell, Terry Jo V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893116/ https://www.ncbi.nlm.nih.gov/pubmed/36741059 http://dx.doi.org/10.3389/fnins.2022.1026065 |
Ejemplares similares
-
Patterns of developmental regression and associated clinical characteristics in SLC6A1-related disorder
por: Kalvakuntla, Sanjana, et al.
Publicado: (2023) -
Current knowledge of SLC6A1-related neurodevelopmental disorders
por: Goodspeed, Kimberly, et al.
Publicado: (2020) -
424 Clinical Translational Approach to Targeted Therapy in SLC6A1-related Neurodevelopmental Disorder
por: Goodspeed, Kimberly, et al.
Publicado: (2023) -
Intrafamilial variability in SLC6A1-related neurodevelopmental disorders
por: Kassabian, Benedetta, et al.
Publicado: (2023) -
Corrigendum: Intrafamilial variability in SLC6A1-related neurodevelopmental disorders
por: Kassabian, Benedetta, et al.
Publicado: (2023)